title: B lymphocyte stimulator: a new target for treating B cell malignancies.
authors: Department of Molecular and Cellular Pharmacology, School of Pharmaceutical and Technology, Tianjin University, Tianjin 300072, China. jsun@public3.bta.net.cn
authors: Jian
authors: J
authors: Sun
authors: Zhou
authors: Z
authors: Lin
authors: Yan
authors: Y
authors: Li
authors: Bei-fen
authors: BF
authors: Shen
mesh_terms: D053264:B-Cell Activating Factor / Q000037:antagonists & inhibitors / Q000378:metabolism; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D008954:Models, Biological; D009101:Multiple Myeloma / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D011485:Protein Binding; D018124:Receptors, Tumor Necrosis Factor / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D053264:B-Cell Activating Factor; C120197:BLyS receptor; D018124:Receptors, Tumor Necrosis Factor